GHTC statement on High-Level Meeting on Tuberculosis delivered at WHA
A statement by GHTC and partners calling on the World Health Organization and member states to close the US$1.3 billion gap in annual tuberculosis (TB) R&D funding was made at the 72nd World Health Assembly. The statement urges countries to invest in the development of new medicines and technologies to treat multidrug-resistant TB and to facilitate rapid and equitable access to these interventions.